Medical device maker Pavmed Inc. (NSDQ:PAVM) topped expectations on Wall Street with its second quarter results today.
The New York-based company posted a net loss of -$989,707, or -8¢ per share, for the 3 months ended June 30, for bottom-line growth of 25% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Pavmed beats Q2 EPS by a penny appeared first on MassDevice.
from MassDevice http://ift.tt/2vBStNc
Cap comentari:
Publica un comentari a l'entrada